You are here: All Products  > Gracell Biotech to Start US Trial of Dual-Targeting CAR-T Therapy for Myeloma

Gracell Biotech to Start US Trial of Dual-Targeting CAR-T Therapy for Myeloma

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products